Status:
COMPLETED
Recurrence and Distant Metastases in Hepatocellular Carcinoma Treated by Transcatheter Arterial Chemoembolization
Lead Sponsor:
Kaohsiung Medical University Chung-Ho Memorial Hospital
Conditions:
Hepatocellular Carcinoma
Eligibility:
All Genders
Brief Summary
This project will include at least 40 patients with hepatocellular carcinoma (HCC) who will receive transcatheter arterial chemoembolization (TACE) as a sole method for the management. The serum is co...
Detailed Description
Transcatheter arterial chemoembolization (TACE) is the traditional method for the palliative management of patients with hepatocellular carcinoma (HCC). This method will cause tissue hypoxia in area o...
Eligibility Criteria
Inclusion
- patients with hepatocellular carcinoma treated by transcatheter arterial chemoembolization
Exclusion
- patients with hepatocellular carcinoma unable to be treated by transcatheter arterial chemoembolization
Key Trial Info
Start Date :
February 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00834028
Start Date
February 1 2007
End Date
December 1 2008
Last Update
February 3 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaohsiung Medical University Hospital
Kaohsiung City, Taiwan, 807